Cargando…

Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?

SIMPLE SUMMARY: The historical standard treatment of metastatic non-small cell lung cancer (NSCLC) consisted of palliative chemotherapy, with limited influence on survival. With the introduction of immuno- and targeted therapy, the prognosis improved largely. A subset of NSCLC patients with limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peeters, Stephanie T. H., Van Limbergen, Evert J., Hendriks, Lizza E. L., De Ruysscher, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125691/ https://www.ncbi.nlm.nih.gov/pubmed/33925139 http://dx.doi.org/10.3390/cancers13092132

Ejemplares similares

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
por: Vanneste, Ben G. L., et al.
Publicado: (2016)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Radiation-induced lung injury — what do we know in the era of modern radiotherapy?
por: Konkol, Marek, et al.
Publicado: (2022)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

Evolutionary ecology of Chagas disease; what do we know and what do we need?
por: Flores‐Ferrer, Alheli, et al.
Publicado: (2017)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Tackling Resistance to Cancer Immunotherapy: What Do We Know?
por: Gondhowiardjo, Soehartati A., et al.
Publicado: (2020)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?
por: Vehbi, Sezan, et al.
Publicado: (2022)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know
por: Castells, Mariana C.
Publicado: (2020)

Geriatric Radiation Oncology: What We Know and What Can We Do Better?
por: Roeder, Falk, et al.
Publicado: (2023)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Neurogenic Stress Cardiomyopathy: What Do We Need to Know
por: Gopinath, Ramachandran, et al.
Publicado: (2018)

Veteran homelessness in Australia: What do we know? What has been done? What do we need to do?
por: Wallace, Duncan, et al.
Publicado: (2023)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Big Tau: What We Know, and We Need to Know
por: Fischer, Itzhak
Publicado: (2023)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

Microplastics in freshwater ecosystems: what we know and what we need to know
por: Wagner, Martin, et al.
Publicado: (2014)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Pneumonia in Bhutanese children: what we know, and what we need to know
por: Jullien, Sophie, et al.
Publicado: (2020)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
por: Ewere, Endurance E, et al.
Publicado: (2021)

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
por: Vanneste, Ben G. L., et al.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

All eyes on Coronavirus—What do we need to know as ophthalmologists
por: Khanna, Rohit C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rk2ejfru3476dtdmihib6k8ekq